Faeth Therapeutics, Inc. (FTH) Tops Q2 EPS by 132c

Faeth Therapeutics, Inc. (NASDAQ: FTH) reported Q2 EPS of ($2.84), $1.32 better than the analyst estimate of ($4.16).

For earnings history and earnings-related data on Faeth Therapeutics, Inc. (FTH) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Bimegren Energy (BESS) files $100M mixed shelf
• OpenAI says its agents leaked some user images - Reuters